Fatigue countermeasures in aviation

Aviation Space and Environmental Medicine

Volumn 80, Issue 1, 2009, Pages 29-59

  Caldwell, John A ^b   Mallis, Melissa M ^c   Caldwell, J Lynn ^a   Paul, Michel A ^d   Miller, James C ^e   Neri, David F ^f  

^a AIR FORCE RESEARCH LABORATORY   (United States)

^b Archinoetics LLC   (United States)

^c Institutes for Behavior Resources   (United States)

^d DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

^e Miller Ergonomics   (United States)

^f OFFICE OF NAVAL RESEARCH   (United States)

Author keywords

Alertness; Duty time regulations; Flight time regulations; Hypnotics; Sleep; Stimulants; Sustained operations

Indexed keywords

CAFFEINE; DEXAMPHETAMINE; ESZOPICLONE; KAVA; MELATONIN; MODAFINIL; NORKOTRAL; PLACEBO; RAMELTEON; STARNOC; TEMAZEPAM; TRIAZOLAM; TYROSINE; UNCLASSIFIED DRUG; VALERIAN; ZALEPLON; ZOLPIDEM; ZOLPIDEM TARTRATE;

AIRCRAFT ACCIDENT; AIRPLANE PILOT; ALERTNESS; ARMY; AVIATION; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; EXERCISE; FATIGUE; FLIGHT; HUMAN; INSOMNIA; KNOWLEDGE; NUTRITION; PHYSICAL ACTIVITY; POLICY; REST; REVIEW; SAFETY; SLEEP; SLEEP DEPRIVATION; UNITED STATES; WORKING TIME;

ACCIDENTS, AVIATION; AEROSPACE MEDICINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CIRCADIAN RHYTHM; FATIGUE; GUIDELINES AS TOPIC; HUMANS; HYPNOTICS AND SEDATIVES; OCCUPATIONAL HEALTH; REST; SLEEP DEPRIVATION; TASK PERFORMANCE AND ANALYSIS; UNITED STATES; WAKEFULNESS; WORK SCHEDULE TOLERANCE; WORKLOAD;

EID: 58149260197     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: 10.3357/ASEM.2435.2009     Document Type: Review

References (237)

1. Aeronautics and Space General operating and flight rules. 14 C.F.R. § 91.1057, 91.1059, 91.1061 (2007a).
2. Aeronautics and Space General operating and flight rules. 14 C.F.R. § 121 (2007b).
3. Aeronautics and Space General operating and flight rules. 14 C.F.R. § 135 (2007c).
4. Afaghi A, O'Connor H, Chow CM. High-glycemic-index carbohydrate meals shorten sleep onset. Am J Clin Nutr 2007; 85:426-30.
5. Ahasan R, Lewko J, Campbell D, Salmoni A. Adaptation to night shifts and synchronisation processes of night workers. J Physiol Anthropol Appl Human Sci 2001; 20:215-26.
6. Akerstedt T. Shift work and disturbed sleep/wakefulness. Occup Med (Lond) 2003; 53:89-94.
7. Angus RG, Pigeau RA, Heslegrave RJ. Sustained-operations studies: from the field to the laboratory. In: Stampi C, ed. Why we nap. Boston: Birkhauser; 1992:217-41.
8. Arendt J. Melatonin characteristics, concerns, and prospects. J Biol Rhythms 2005; 20:291-303.
9. Arendt JT, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev 2005; 9:25-39.
10. Arnulf I, Quintin P, Alvarez JC, Vigil L, Touitou Y, Lèbre AS, et al. Mid-morning tryptophan depletion delays REM sleep onset in healthy subjects. Neuropsychopharmacology 2002; 27:843-51.
11. Atkinson G, Edwards B, Reilly T, Waterhouse J. Exercise as a synchronizer of human circadian rhythms: an update and discussion of the methodological problems. Eur J Appl Physiol 2007; 99:331-41.
12. Australian Government Civil Aviation Safety Authority. Civil Aviation Orders. Flight time limitations -pilots Part 48, Section 48.1, Issue 9 -December 8, 2004, Amdt. No. 29. http://www.casa.gov.au/download/orders/cao48/4801.pdf.
13. Australian Government Civil Aviation Safety Authority. Rules watch. Flight Safety Australia 2008; 60:50-1.
14. Balter MB, Uhlenhuth EH. New epidemiologic findings about insomnia and its treatment. J Clin Psychiatry 1992; 53(Suppl. 12):34-9.
15. Barger LK. Wright KP, Jr, Hughes RJ, Czeisler CA. Daily exercise facilitates phase delays of circadian melatonin rhythm in very dim light. Am J Physiol Regul Integr Comp Physiol 2004; 286:R1077-84 Epub 2004 Mar 18.
16. Bartholini G. Growing aspects of hypnotic drugs. In: Sauvanet JP, Langer SZ, Morselli PL, eds. Imidazopyridines in sleep disorders. New York: Raven Press; 1988:1-9.
17. Belenky G, Wesensten NJ, Thorne DR, Thomas ML, Sing HC, Redmond DP, et al. Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study. J Sleep Res 2003; 12:1-12.
18. Belland KM, Bissell C. A subjective study of fatigue during navy flight operations over southern Iraq: Operation Southern Watch. Aviat Space Environ Med 1994; 65:557-61.
19. Belyavin A, Spencer MB. Modeling performance and alertness: the QinetiQ approach. Aviat Space Environ Med 2004; 75(3, Suppl.):A93-A103.
20. Berka C, Levendowski DJ, Cvetinovic MM, Petrovic MM, Davis G, Lumicao MN, et al. Real-time analysis of EEG indexes of alertness, cognition, and memory acquired with a wireless EEG headset. Int J Hum Comput Interact 2004; 17:151-70.
21. Blois R, Gaillard J, Attali P, Coqueline J. Effect of zolpidem on sleep in healthy subjects: a placebo controlled trial with polysomnographic recordings. Clin Ther 1993; 15:797-809.
22. Bonnet MH. Dealing with shift work: physical fitness, temperature, and napping. Work Stress 1990; 4:261-74.
23. Bonnet MH. The effect of varying prophylactic naps on performance, alertness and mood throughout a 52-hour continuous operation. Sleep 1991; 14:307-15.
24. Bonnet MH. Acute sleep deprivation. In: Kryger MA, Roth T, Dement WC, eds. Principles and practice of sleep medicine. Philadelphia: Elsevier Saunders; 2005:51-66.
25. Bonnet MH, Arand DL. Clinical effects of sleep fragmentation versus sleep deprivation. Sleep Med Rev 2003; 7:293-310.
26. Booth-Bourdeau J, Marcil I, Laurence M, McCulloch K, Dawson D. Development of fatigue risk management systems for the Canadian aviation industry. Proceedings of the 2005 International Conference on Fatigue Management in Transportation Operations; 2005 September 11-15; Seattle. WA: Transport Canada; 2005.
27. Boulos Z, Campbell SS, Lewy AJ, Terman M, Dijk D, Eastman CI. Light treatment for sleep disorders: consensus report. VI. Jet lag. J Biol Rhythms 1995; 10:167-76.
28. Bourgeois-Bougrine S, Carbon P, Gounelle C, Mollard R, Coblentz A. Perceived fatigue for short- and long-haul flights: a survey of 739 airline pilots. Aviat Space Environ Med 2003; 74:1072-7.
29. Bricknell MCM. Sleep manipulation prior to airborne exercises. J R Army Med Corps 1991; 137:22-6.
30. Brooks A, Lack L. A brief afternoon nap following nocturnal sleep restriction: which nap duration is most recuperative? Sleep 2006; 29:831-40.
31. Brown ID. Prospectus for technological countermeasures against driver fatigue. Accid Anal Prev 1997; 29:525-31.
32. Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, et al. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 2005; 9:41-50.
33. Burgess HJ, Sharkey KM, Eastman CI. Bright light, dark and melatonin can promote circadian adaptation in night shift workers. Sleep Med Rev 2002; 6:407-20.
34. Burgess HJ, Revell VL, Eastman CI. A three pulse phase response curve to three milligrams of melatonin in humans. J Physiol 2008; 586:639-47.
35. Buxton OM, Lee CW, L'Hermite-Baleriaux M, Turek FW, Van Cauter E. Exercise elicits phase shifts and acute alterations of melatonin that vary with circadian phase. Am J Physiol Regul Integr Comp Physiol 2003; 284:R714-24.
36. Cabon P, Bourgeois-Bougrine S, Mollard R, Coblentz A, Speyer JJ. Electronic pilot-activity monitor: a countermeasure against fatigue on long-haul flights. Aviat Space Environ Med 2003; 74(6 Pt 1):679-82.
37. Cabon P, Coblentz A, Mollard R, Fouillot JP. Human vigilance in railway and long-haul flight operation. Ergonomics 1993; 36:1019-33.
38. Cajochen C. Alerting effects of light. Sleep Med Rev 2007; 11:453-64.
39. Cajochen C, Khalsa SB, Wyatt JK, Czeisler CA, Dijk DJ. EEG and ocular correlates of circadian melatonin phase and human performance decrements during sleep loss. Am J Physiol 1999; 277:R640-9.
40. Cajochen C, Zeitzer JM, Czeisler CA, Dijk DJ. Dose response relationship for light intensity and ocular and electroencephalographic correlates of human alertness. Behav Brain Res 2000; 115:75-83.
41. Caldwell JA. Efficacy of stimulants for fatigue management: the effects of Provigil and Dexedrine on sleep-deprived aviators. Transportation Research Part F: Traffic Psychology and Behaviour 2001; 4 (1):19-37.
42. Caldwell JA, Caldwell JL. An in-flight investigation of the efficacy of dextroamphetamine for sustaining helicopter pilot performance. Aviat Space Environ Med 1997; 68:1073-80.
43. Caldwell JA, Caldwell JL. Comparison of the effects of zolpidem-induced prophylactic naps to placebo naps and forced rest periods in prolonged work schedules. Sleep 1998; 21:79-90.
44. Caldwell JA, Caldwell JL, Crowley JS. Sustaining female helicopter pilot performance with Dexedrine during sustained operations. Int J Aviat Psychol 1997; 7:15-36.
45. Caldwell JA, Caldwell JL, Crowley JS, Jones HD. Sustaining helicopter pilot performance with Dexedrine during periods of sleep deprivation. Aviat Space Environ Med 1995; 66:930-7.
46. Caldwell JA, Caldwell JL, Smith JK, Alvarado L, Heintz T, Mylar JT, et al. The efficacy of modafinil for sustaining alertness and simulator flight performance in F-117 pilots during 37 hours of continuous wakefulness. Brooks City-Base, TX: U.S. Air Force Research Laboratory; 2004 Jan. Report No. AFRL-HE-BR-TR-2004-0003.
47. Caldwell JA, Caldwell JL, Smythe NK, Hall KK. A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining alertness and performance of aviators: a helicopter simulator study. Psychopharmacology (Berl) 2000; 150:272-82.
48. Caldwell JA, Gilreath SR. A survey of aircrew fatigue in a sample of Army aviation personnel. Aviat Space Environ Med 2002; 73:472-80.
49. Caldwell JA, Prazinko B, Caldwell JL. Body posture affects electroencephalographic activity and psychomotor vigilance task performance in sleep-deprived subjects. Clin Neurophysiol 2003; 114:23-31.
50. Caldwell JA, Smythe NK, LeDuc PA, Caldwell JL. Efficacy of dextroamphetamine for the maintenance of aviator performance during 64 hours of sustained wakefulness. Aviat Space Environ Med 2000; 71:7-18.
51. Caldwell JL, Gilreath SR. Work and sleep hours of U.S. Army aviation personnel working reverse cycle. Mil Med 2001; 166:159-66.
52. Caldwell JL, Prazinko BF, Rowe T, Norman D, Hall KK, Caldwell JA. Improving daytime sleep with temazepam as a countermeasure for shift lag. Aviat Space Environ Med 2003; 74:153-63.
53. Carskadon MA. Ontogeny of human sleepiness as measured by sleep latency. In: Dinges DF, Broughton RJ, eds. Sleep and alertness: chronobiological, behavioral, and medical aspects of napping New York: Raven Press; 1989:53-69.
54. Chagan L, Cicero LA. Zaleplon: A possible advance in the treatment of insomnia. P&T 1999; 24:590-9.
55. Co EL. Gregory KB, Johnson JM, & Rosekind MR. Crew factors in flight operations XI: A survey of fatigue factors in regional airline operations. Moffett Field, CA: NASA Ames Research Center; 1999. Report No: NASA/TM - 1999-208799.
56. Committee on Military Nutrition Research. Caffeine for the sustainment of mental task performance: Formulations for military operations. Washington, DC: National Academy Press 2001.
57. Comperatore CA, Caldwell JA, Caldwell JL. Leader's guide to crew endurance. Instructional brochure on crew work/rest scheduling, circadian rhythms, fatigue, and fatigue countermeasures. Fort Rucker, AL: U.S. Army Aeromedical Research Laboratory and the U.S. Army Safety Center, 1997.
58. Cornum KG, Cornum R, Storm W. Use of psychostimulants in extended flight operations: a Desert Shield experience. In: Advisory Group for Aerospace Research and Development Conference Proceedings No. 579, Neurological Limitations of Aircraft Operations: Human Performance Implications. Neuilly-sur-Seine, France: NATO Advisory Group for Aerospace Research and Development; 1996:371-4.
59. Cornum R, Caldwell JA, Cornum KG. Stimulant use in extended flight operations. Airpower J 1997; 11(1):53-8.
60. Cosenzo KA, Fatkin LT, Patton DJ. Ready or not: enhancing operational effectiveness through use of readiness measures. Aviat Space Environ Med 2007; 75(5, Suppl.):B96-106.
61. Costa G. The problem: shiftwork. Chronobiol Int 1997; 14:89-98.
62. Daan S, Lewy AJ. Scheduled exposure to daylight: a potential strategy to reduce "jet lag" following transmeridian flight. Psychopharmacol Bull 1984; 20:566-8.
63. Dijk DJ, Franken P. Interaction of sleep homeostasis and circadian rhythmicity: dependent or independent systems? In: Kryger MA, Roth T, Dement WC, eds. Principles and practice of sleep medicine. Philadelphia: Elsevier Saunders; 2005: 418-434.
64. Dijkman M, Sachs N, Levine E, Mallis M, Carlin MM, Gillen KA, et al. Effects of reduced stimulation on neurobehavioral alertness depend on circadian phase during human sleep deprivation. Sleep Res 1997; 26:265.
65. Dinges DF. Differential effects of prior wakefulness and circadian phase on nap sleep. Electroencephalogr Clin Neurophysiol 1986; 64:224-7.
66. Dinges DF. Critical research issues in development of biomathematical models of fatigue and performance. Aviat Space Environ Med 2004; 75(3, Suppl)A181-91.
67. Dinges DF, Graeber RC, Rosekind MR, Samel A, Wegmann HM. Principles and guidelines for duty and rest scheduling in commercial aviation. Moffett Field, CA: NASA Ames Research Center; 1996. Report No: 110404.
68. Dinges DF, Maislin G, Brewster RM, Krueger GP, Carroll RJ. Pilot test of fatigue management technologies. Washington, DC: Transportation Research Board of the National Academies, Journal of the Transportation Research Board; 2005 Report No. 1922.
69. Dinges DF, Mallis MM. Managing fatigue by drowsiness detection: can technological promises be realized? In: Hartley L, eds. Managing fatigue in transportation. Kidlington, Oxford, UK: Elsevier Science Ltd; 1998: 209-29.
70. Dinges DF, Mallis MM, Maislin G, Powell JW. Final report: evaluation of techniques for ocular measurement as an index of fatigue and as the basis for alertness management. Washington, DC: National Highway Traffic Safety Administration; 1998 Report No: DOT HS 808 762.
71. Dinges DF, Orne MT, Orne EC. Assessing performance upon abrupt awakening from naps during quasi-continuous operations. Behav Res Methods Inst Comput 1985; 17:37-45.
72. Dinges DF, Price NJ, Maislin G, Powell JW, Ecker AJ, Mallis MM. Szuba, et al. Prospective laboratory re-validation of ocular-based drowsiness detection technologies and countermeasures. In: Wierwille WW, Hanowski RJ, Olson RL, Dinges DF, Price NJ, Maislin G, et al. NHTSA Drowsy Driver Detection And Interface Project: Subtask A; 2002; Report No: DTNH 22-00-D-07007.
73. Dinges DF, Rider RL, Dorrian J, McGlinchey EL, Rogers NL, Cizman Z, et al. Optical computer recognition of facial expressions associated with stress induced by performance demands. Aviat Space Environ Med 2005; 76(6, Suppl)B172-82.
74. Dinges DF, Whitehouse WG, Orne EC, Orne MT. The benefits of a nap during prolonged work and wakefulness. Work Stress 1988; 2:139-53.
75. Driskell JE, Mullen B. The efficacy of naps as a fatigue countermeasure: a meta-analytic integration. Hum Factors 2005; 47:360-77.
76. Driver HS, Taylor SR. Sleep and exercise. Sleep Med Rev 2000; 4:387-402.
77. Duffy JF, Wright KP. Entrainment of the human circadian system by light. J Biol Rhythms 2005; 20:326-38.
78. Eastman CI, Boulos Z, Terman M, Campbell SS, Dijk D, Lewy AJ. Light treatment for sleep disorders: consensus report. VI. shift work. J Biol Rhythms 1995; 10:157-64.
79. Ebert B, Wafford KA, Deacon S. Treating insomnia: current and investigational pharmacological approaches. Pharmacol Ther 2006; 112:612-29.
80. Elie R, Ruther E, Farr I, Emilien G, Salinas E. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. J Clin Psychiatry 1999; 60:536-44.
81. Emonson DL, Vanderbeek RD. The use of amphetamine in U.S. Air Force tactical operations during Desert Shield and Storm. Aviat Space Environ Med 1995; 66:260-3.
82. Fabiani M, Gratton G, Coles MG Event-related brain potentials In: Caciooppo JT, Tassinary LG, Bemtson GG, eds. Handbook of psychophysiology. Cambridge, England: Cambridge University Press; 2000:53-84.
83. Flight Safety Foundation. Lessons from the dawn of ultra-long-range flight. Flight Saf Dig 2005; Aug-Sept:1-60.
84. Folkard S, Tucker P. Shift work, safety and productivity. Occup Med 2003; 53:95-101.
85. Fry J, Scharf M, Mangano R, Fujimori M. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Int Clin Psychopharmacol 2000; 15:141-52.
86. Galinsky T, Swanson N, Sauter S, Dunkin R, Hurrell J, Schleifer L. Supplementary breaks and stretching exercises for data entry operators: a follow-up field study. Am J Ind Med 2007; 50:519-27.
87. Gander PH, Graeber RC, Connell LJ, Gregory KB. Crew factors in flight operations VIII: factors influencing sleep timing and subjective sleep quality in commercial long-haul flight crews. Moffett Field, CA: NASA; 1991. Technical Memorandum 103852.
88. Gander PH, Myhre G, Graeber RC, Anderson HT, Lauber JK. Adjustment of sleep and the circadian temperature rhythm after flights across nine time zones. Aviat Space Environ Med 1989; 60:733-43.
89. Gillberg M. The effects of two alternative timings of a one-hour nap on early morning performance. Biol Psychol 1984; 19:45-54.
90. Gillberg M. Sleepiness and its relation to the length, content, and continuity of sleep. J Sleep Res 1995; 4(Suppl. 2):37-40.
91. Gilliland K, Schlegel RE. Readiness to perform: a critical analysis of the concept and current practices. Oklahoma City, OK: Office of Aviation Medicine, Federal Aviation Administration. NTIS No. AD 1993; A269:379.
92. Goldsmith C. More carriers sanction their pilots' cockpit snoozes. The Wall Street Journal 1998 Jan 21, B1.
93. Greenblatt DJ, Zammit G, Harmatz J, Legangneux E. Zolpidem modified-release demonstrates sustained and greater pharmacodynamic effects from 3 to 6 hours postdose as compared with standard zolpidem in healthy adult subjects. [Abstract] Sleep 2005; 28(Suppl.):A245.
94. Gu H, Ji Q. An automated face reader for fatigue detection. Proceedings of the Sixth IEEE International Conference on Automatic Face and Gesture Recognition; 2004. Los Alamitos, CA: IEEE; 2004:111-6.
95. Hadley S, Petry JJ. Valerian. Am Fam Physician 2003; 67:1755-8.
96. Heslegrave RJ, Angus RG. The effects of task duration and work-session location on performance degradation induced by sleep loss and sustained cognitive work. Behav Res Methods Inst Comput 1985; 17:592-603.
97. Ho P, Landsberger S, Signal L, Singh J, Stone B. The Singapore experience: task force studies scientific data to assess flights. Flight Safety Digest 2005; 24(8-9):20-40.
98. Horne JA, Foster SC. Can exercise overcome sleepiness? [Abstract] Sleep Research 1995; 24A:437.
99. Horowitz TS, Tanigawa T. Circadian-based new technologies for night workers. Ind Health 2002; 40:223-36.
100. Hursh SR, Raslear TG, Kaye SA, Fanzone JF Jr. Validation and calibration of a fatigue assessment tool for railroad work schedules, summary report. Washington, DC: Department of Transportation; 2006; DOT/FRA/ORD-06/21, October 31, 2006.
101. Hursh SR, Redmond DP, Johnson ML, Thorne DR, Belenky TJ, Storm WF, et al. Fatigue models for applied research in warfighting. Aviat Space Environ Med 2004; 75(3, Suppl.):A44-A53.
102. Ji Q, Zhu Z, Lan P. Real-time nonintrusive monitoring and prediction of driver fatigue Vehicular Technology. IEEE Transactions 2004; 53:1052-68.
103. Kirsch AD. Report on the statistical methods employed by the U.S. Federal Aviation Administration in its cost/benefit analysis of the proposed flight crewmember duty period limitations, flight time limitations and rest requirements. Washington, DC; United States Federal Aviation Administration; 1996. Docket No: 28081.
104. Kithil PW, Jones RD, MacCuish J. Development of driver alertness detection system using overhead capacitive sensor array. 2006; Retrieved from http://internet.cybermesa.com/~roger_jones/drowsy.htm.
105. Klein KE, Bruner H, Holtmann H, Rehme H, Stolze J, Steinhoff WD, et al. Circadian rhythm of pilots' efficiency and effects of multiple time zone travel. Aerosp Med 1970; 41:125-32.
106. Klein KE, Wegmann HM. Significance of circadian rhythms in aerospace operations. AGARDograph No. 247, 1980. Neuilly-sur-Seine, France.
107. Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T; ZOLONG Study Group. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 2008; 31:79-90.
108. Lagarde D, Batejat D. Disrupted sleep-wake rhythm and performance: Advantages of modafinil. Mil Psychol 1995; 7:165-91.
109. Lal SKL, Craig A. Reproducibility of the spectral components of the electroencephalogram during driver fatigue. Int J Psychophysiol 2005; 55:137-43.
110. Landström U, Knutsson A, Lennernäs M, Söderberg L. Laboratory studies of the effects of carbohydrate consumption on wakefulness. Nutr Health 2000; 13:213-25.
111. Lavie P. Ultrashort sleep-waking schedule. III. "Gates" and "forbidden zones" for sleep. Electroencephalogr Clin Neurophysiol 1986; 63:414-25.
112. Lavine RA, Sibert JL, Gokturk M, Dickens B. Eye-tracking measures and human performance in a vigilance task. Aviat Space Environ Med 2002; 73:367-72.
113. LeDuc PA, Caldwell JA, Ruyak PS. The effects of exercise versus napping on alertness and mood in sleep-deprived aviators. Fort Rucker, AL: U.S. Aeromedical Research Laboratory; 2000; Technical Report 2000-12.
114. Leese P, Maier G, Vaickus L, Akylbekova E. Esopiclone: pharmacokinetic and pharmacodynamic effects of a novel sedative hypnotic after daytime administration in healthy subjects. [Abstract] Sleep 2002; 25(Suppl.):A45.
115. Levendowski DJ, Berka C, Olmstead RE, Jarvik M. Correlations between EEG indices of alertness measures of performance and self-reported states while operating a driving simulator. [Abstract]. 29th Annual Meeting, Society for Neuroscience; 1999 October 25; Miami Beach, FL. Washington, DC Soceity for Neuroscience; 1999; Vol. 25.
116. Levendowski DJ, Olmstead RE, Konstantinovic ZR, Berka C, Westbrook PR. Detection of electroencephalographic indices of drowsiness in real time using a multi-level discriminant function analysis. Sleep 2000; 23(Abstract Suppl. 2):A243-4
117. Lewy AJ, Bauer VK, Ahmed S, Thomas KH, Cutler NL, Singer CM, et al. The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light. Chronobiol Int 1998; 15:71-83.
118. Lewy AJ, Emens J, Jackman A, Yuhas K. Circadian uses of melatonin in humans. Chronobiol Int 2006; 23:403-12.
119. Lieberman JA. Update on the safety considerations in the management of insomnia with hypnotics: Incorporating modified-release formulations into primary care. Prim Care Companion J Clin Psychiatry 2007; 9:25-31.
120. Lin C, Wu R, Jung T, Liang S, Huang T. Estimating driving performance based on EEG spectrum analysis. EURASIP J Appl Signal Processing 2005; 19:3165-74.
121. Lobb ML, Stern JA. Pattern of eyelid motion predictive of decision errors during drowsiness: oculomotor indices of altered states. Int J Neurosci 1986; 30:17-22.
122. Lockley SW, Evans EE, Scheer FA, Brainard GC, Czeisler CA, Aeschbach D. Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep 2006; 29:161-8.
123. Lucero K, Hicks RA. Relationship between habitual sleep duration and diet. Percept Mot Skills 1990; 71(3 Pt 2):1377-8.
124. Luna T. Fatigue in context: USAF mishap experience. [Abstract] Aviat Space Environ Med 2003; 74:388.
125. Mallis M, Maislin G, Konowal N, Byrne V, Bierman D, Davis R, et al. Biobehavioral responses to drowsy driving alarms and alerting stimuli. Washington, DC: U.S. Department of Transportation; 1998; Final Report: 1-127.
126. Mallis MM, Mejdal S, Nguyen TT, Dinges DF. Summary of the key features of seven biomathematical models of human fatigue and performance. Aviat Space Environ Med 2004; 75:A4-14.
127. Mallis MM, Neri DF, Colletti LM, Oyung RL, Reduta DD, Van Dongen H, et al. Feasibility of an automated drowsiness monitoring device on the flightdeck. Sleep 2004; 27(Abstract Suppl.):A167-8.
128. Matsumoto K, Harada M. The effect of night-time naps on recovery from fatigue following night work. Ergonomics 1994; 37:899-907.
129. Matsumoto Y, Mishima K, Satoh K, Shimizu T, Hishikawa Y. Physical activity increases the dissociation between subjective sleepiness and objective performance levels during extended wakefulness in human. Neurosci Lett 2002; 326:133-6.
130. Melfi ML, Miller JC. Causes and effects of fatigue in experienced military aircrew and the countermeasures needed to improve flight safety. Brooks City-Base, TX: Air Force Research Laboratory; 2006 Jan. Report No AFRL-HE-BR-TR-2006-0071.
131. Menkes DB. Hypnosedatives and anxiolytics. In: Dukes MNG, Aronson JK, eds. Meyler's side effects of drugs, 14th ed. Amsterdam: Elsevier Science; 2000: 121-38.
132. Mitler MM, Aldrich MS. Stimulants: efficacy and adverse effects. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. 3rd ed. Philadelphia: W.B. Saunders Co; 2000: 429-40.
133. Mitler MM, Carskadon MA, Phillips RL, Sterling WR, Zarcone VP, Jr., Spiegels R, et al. Hypnotic efficacy of temazepam: a long-term sleep laboratory evaluation. Br J Clin Pharmacol 1979; 8:63S-8S.
134. Mohler SR. Clinical problems in aviation medicine: fatigue in aviation activities. Aerosp Med 1966; 37:722-32.
135. Moja EA, Antinoro E, Cesa-Bianchi M, Cessa GL. Increase in stage 4 sleep after ingestion of a tryptophan-free diet in humans. Pharmacol Res Commun 1984; 16:909-14.
136. Monti JM. Primary and secondary insomnia: prevalence, causes and current therapeutics. Curr Med Chem Cent Nerv Syst Agents 2004; 4:119-37.
137. Morin AK. Strategies for treating chronic insomnia. Am J Manag Care 2006; 12:S230-46.
138. Muller FO, Dyk MV, Hundt HKL, Joubert AL, Luus HG, Groenewoud G, et al. Pharmacokinetics of temazepam after day-time and night-time oral administration. Eur J Clin Pharmacol 1987; 33:211-4.
139. National Transportation Safety Board. A review of flightcrew-involved, major accidents of U.S. air carriers, 1978 through 1990. Washington, DC: National Transportation Safety Board; 1994. Report No: NTSB Safety Study No. SS-94-01.
140. st Sess., 35-37 (2007) (testimony of William R. Voss).
141. National Sleep Foundation. 2002 Sleep in America poll. Washington: National Sleep Foundation 2002.
142. Nehlig A. Are we dependent upon coffee and caffeine? a review on human and animal data. Neurosci Biobehav Rev 1999; 23:563-76.
143. Neri DF. Scientific and operational issues associated with ultra long range flight [Abstract]. Aviat Space Environ Med 2005; 76:247
144. Neri DF, Oyung RL, Colletti LM, Mallis MM, Tam PY, Dinges DF. Controlled breaks as a fatigue countermeasure on the flight deck. Aviat Space Environ Med 2002; 73:654-64.
145. Neri DF, Wiegmann D, Stanny RR, Shappell SA, McCardie A, McKay DL. The effects of tyrosine on cognitive performance during extended wakefulness. Aviat Space Environ Med 1995; 66:313-9.
146. Neumann M, Jacobs KW. Relationship between dietary components and aspects of sleep. Percept Mot Skills 1992; 75(3 Pt 1):873-4.
147. Neville KJ, Bisson RU, French J, Boll PA, Storm WF. Subjective fatigue of C-141 aircrews during Operation Desert Storm. Hum Factors 1994; 36:339-49.
148. Newhouse PA, Penetar DM, Fertig JB, Thorne DR, Sing HC, Thomas ML, et al. Stimulant drug effects on performance and behavior after prolonged sleep deprivation: a comparison of amphetamine, nicotine, and deprenyl. Mil Psychol 1992; 4:207-33.
149. Nicholson AN. Hypnotics and occupational medicine. J Occup Med 1990; 32:335-41.
150. Nicholson AN, Pascoe PA, Spencer MB, Stone BM, Roehrs TA, Roth T. Sleep after transmeridian flights. Lancet 1986; 2:1205-8.
151. Nicholson AN, Roth T, Stone BM. Hypnotics and aircrew. Aviat Space Environ Med 1985; 56:299-303.
152. Nicholson AN, Stone BM. Sleep and wakefulness handbook for flight medical officers. Neuilly-sur-Seine, France: Advisory Group for Aerospace Research and Development; 1982.
153. Nicholson AN, Stone BM, Pascoe PA. Efficacy of some benzodiazepines for day-time sleep. Br J Clin Pharmacol 1980; 10:459-63.
154. Oren DA, Reich W, Rosenthal NE, Wehr TA. How to beat jet lag: a practical guide for air travelers. New York: Henry Holt; 1993.
155. Owasoyo JO, Neri DF, Lamberth JG. Tyrosine and its potential use as a countermeasure to performance decrement in military sustained operations. Aviat Space Environ Med 1992; 63:364-9.
156. Palminteri R, Narbonne G. Safety profile of zolpidem. In: Sauvanet JP, Langer SZ, Morselli PL, eds. Imidazopyridines in sleep disorders. New York: Raven Press; 1988:351-60.
157. Paul MA, Gray G, Kenny G, Pigeau R. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance. Aviat Space Environ Med 2003; 74:1263-70.
158. Paul MA, Gray G, MacLellan M, Pigeau RA. Sleep-inducing pharmaceuticals: a comparison of melatonin, zaleplon, zopiclone, and temazepam. Aviat Space Environ Med 2004; 75:512-9.
159. Physician's Desk Reference. Modafinil. In: Physician's Desk Reference. Montvale, NJ: Thomson PDR; 2003:1193-6.
160. Pigeau R, Naitoh P, Buguet A, McCann C, Baranski J, Taylor M, et al. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work, effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 1995; 4:212-28.
161. PMl, Inc. FIT Workplace Safety Screener: theory and validation. Rockville, MD: PMI, Inc 1999.
162. Porcu S, Bellatreccia A, Ferrara M, Casagrande M. Performance, ability to stay awake, and tendency to fall asleep during the night after a diurnal sleep with temazepam or placebo. Sleep 1997; 20:535-41.
163. Portas CM, Bjorvatn B, Ursin R. Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies. Prog Neurobiol 2000; 60:13-35.
164. Porter JM, Home JA. Bed-time food supplements and sleep: effects of different carbohydrate levels. Electroencephalogr Clin Neurophysiol 1981; 51:426-33.
165. Prazinko BF, Sam JA, Caldwell JL, Townsend AT. Dose uniformity of over-the-counter melatonin as determined by high-pressure liquid chromatography. Fort Rucker, AL: U. S. Army Aeromedical Research Laboratory; 2000; USAARL Technical Report 2000-23.
166. Ramsey CS, McGlohn SE. Zolpidem as a fatigue countermeasure. Aviat Space Environ Med 1997; 68:926-31.
167. Reid KJ, Burgess HJ. Circadian rhythm sleep disorders. Prim Care 2005; 32:449-73.
168. Revell VL, Eastman CI. How to trick Mother Nature into letting you fly around or stay up all night. J Biol Rhythms 2005; 20:353-65.
169. Robertson P, Hillriegel ET. Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet 2003; 42:123-37.
170. Roehrs T, Burduvali E, Bonahoom A, Drake C, Roth T. Ethanol and sleep loss: a "dose" comparison of impairing effects. Sleep 2003; 26:981-5.
171. Rogers AS, Spencer MB, Stone BM, Nicholson AN. The influence of a 1 h nap on performance overnight. Ergonomics 1989; 32:1193-205.
172. Roky R, Chapatot F, Benchekroun MT, Benaji B, Hakkou F, Elkhalifi H, et al. Daytime sleepiness during Ramadan intermittent fasting: polysomnographic and quantitative waking EEG study. J Sleep Res 2003; 12:95-101.
173. Roky R, Chapatot F, Hakkou F, Benchekroun MT, Benaji B, Buguet A. Sleep during Ramadan intermittent fasting. J Sleep Res 2001; 10:319-27.
174. Rosa RR. Napping at home and alertness on the job in rotating shift workers. Sleep 1993; 16:727-35.
175. Rosekind MR, Co EL, Gregory KB, Miller DL. Crew factors in flight operations XIII: a survey of fatigue factors in corporate/executive aviation operations. Moffett Field, CA: NASA Ames Research Center; 2000. Report No.: NASA/TM-2000-209610.
176. Rosekind MR, Gander PH, Connell LJ, Co EL. Crew factors in flight operations X: alertness management in flight operations education module. Moffett Field, California: National Aeronautics and Space Administration; 2001; NASA Technical Memorandum No. 2001-211385.
177. Rosekind MR, Graeber RC, Dinges DF, Connell LJ, Rountree MS, Spinweber CL, et al. Crew factors in flight operations IX: effects of planned cockpit rest on crew performance and alertness in long-haul operations. Moffett Field, CA: NASA Ames Research Center; 1994; Report No: DOT/FAA/92/24.
178. Rosekind MR, Gregory KB, Miller DL, Co EI, Lebacqz JV, Brenner M. Crew fatigue factors in the Guantanamo Bay aviation accident. [Abstract] Sleep Res 1996; 25:571.
179. Rosekind MR, Miller DL, Gregory KB, Dinges DF. Crew factors in flight operations XII: a survey of sleep quantity and quality in on-board crew rest facilities. Moffett Field, CA: NASA; 2000; Report No: NASA/TM-2000-20961.
180. Roth T, Piccione P, Salis P, Kramer M, Kaffeman M. Effects of temazepam, flurazepam and quinalbarbitone on sleep: psychomotor and cognitive function. Br J Clin Pharmacol 1979; 8:47S-54S.
181. Roth T, Roehrs T. A review of the safety profiles of benzodiazepine hypnotics. J Clin Psychiatry 1991; 52(9, Suppl)38-47.
182. Rowland L, Thomas M, Thorne D, Sing H, Davis HQ, Redmond D, et al. Oculomotor changes during 64 hours of sleep. [Abstract] Sleep Res 1997; 26:626.
183. Russo M, Thomas M, Sing H, Thorne D, Balkin T, Wesensten N, et al. Saccadic velocity and pupil constriction latency changes in partial sleep deprivation, and correlations with simulated motor vehicle crashes. Sleep 1999;22(Suppl. 1):S297-8.
184. Russo M, Thomas M, Thorne D, Sing H, Redmond D, Rowland L, et al. Oculomotor impairment during chronic partial sleep deprivation. Elsevier Science Ireland, Ltd. for the International Federation of Clinical Neurophysiology, 2003; 114:723-736.
185. Sack RL, Auckley D, Auger RR, Carskadon MA, Wright KP, Jr., Vitiello MV, et al. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep 2007; 30:1460-83.
186. Samel A, Wegmann HM, Vejvoda M. Jet lag and sleepiness in aircrew. J Sleep Res 1995; 4(S2):30-6.
187. Samel A, Wegmann HM, Vejvoda M. Aircrew fatigue in long-haul operations. Accid Anal Prev 1997; 29:439-52.
188. Sanger DJ, Perrault G, Morel E, Joly D, Zivkovic B. The behavioral profile of zolpidem, a novel hypnotic drug of Imidazopyridine structure. Physiol Behav 1987; 41:235-40.
189. Schultz D, Miller JC. Fatigue and use of go/no-go pills in extraordinarily long combat sorties [Commentary]. Aviat Space Environ Med 2004; 75:370-1.
190. Schultz D, Miller JC. Fatigue and use of go/no go pills in F-16 pilots subjected to extraordinarily long combat sorties Brooks City-Base, TX: Air Force Research Laboratory; 2004 Apr.; Technical report: AFRL-HE-BR-TR-2004-0014.
191. Schweitzer PK, Muehlback MJ, Walsh JK. Countermeasures for night work performance deficits: the effect of napping or caffeine on continuous performance at night. Work Stress 1992; 6:355-65.
192. Senechal PK. Flight surgeon support of combat operations at RAF Upper Heyford. Aviat Space Environ Med 1988; 59:776-7.
193. Shiota M, Sudou M, Ohshima M. Using outdoor exercise to decrease jet lag in airline crewmembers. Aviat Space Environ Med 1996; 67:1155-60.
194. Signal L, Gander P, van den Berg M. Sleep during ultra-long range flights: a study of sleep on board the 777-200 ER during rest opportunities of 7 hours. Report Published for the Boeing Commercial Airplane Group Sleep/Wake Research Centre, Massey University. Wellington, New Zealand: 2003.
195. Signal L, Ratieta D, Gander P. Fatigue management in the New Zealand aviation industry. Australian Transport Safety Bureau Research and Analysis Report April, 2006.
196. Skene DJ, Arnedt J. Human circadian rhythms: physiological and therapeutic relevance of light and melatonin. Ann Clin Biochem 2006; 43:344-53.
197. Spring B, Maller O, Wurtman J, Digman L, Cozolino L. Effects of protein and carbohydrate meals on mood and performance: interactions with sex and age. J Psychiatr Res 1982-1983; 17:155-67.
198. Spurgeon A. Working time: its impact on safety and health. International Labour Office Report. Geneva: International Labour Organization, 2003.
199. Stepanski EJ, Wyatt JK. Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev 2003; 7:215-25.
200. th annual IASS; 2006 Oct 23-25; Paris, France. Alexandria, VA: Flight Safety Foundation; 2006.
201. Stone BM, Turner C. Promoting sleep in shiftworkers and intercontinental travelers. Chronobiol Int 1997; 14:133-43.
202. Suhner A, Schlagenhauf P, Hofer I, Johnson R, Tschopp A, Steffen R. Effectiveness and tolerability of melatonin and zolpidem for the alleviation of jet lag. Aviat Space Environ Med 2001; 72:638-46.
203. Taibi DM, Landis CA, Petry H, Vitiello MV. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev 2007; 11:209-30.
204. Tietzel AJ, Lack LC. The short-term benefits of brief and long naps following nocturnal sleep restriction. Sleep 2001; 24:293-300.
205. Tilley AJ, Wilkinson RT, Warren PSG, Watson B, Drud M. The sleep and performance of shift workers. Hum Factors 1982; 24:629-41.
206. Touitou Y, Bogdan A. Promoting adjustment of the sleep-wake cycle by chronobiotics. Physiol Behav 2007; 90:294-300.
207. Tsai YF, Viirre E, Strychacz C, Chase B, Jung TP. Task performance and eye activity: predicting behavior relating to cognitive workload. Aviat Space Environ Med 2007; 78(5, Suppl) B176-85.
208. Tucker P, Folkard S, Macdonald I. Rest breaks and accident risk. Lancet 2003; 361(9358):680.
209. U.S. National Library of Medicine and the National Institutes of Health. Drug information: Temazepam. In: Medline Plus; 2004. www.nlm.nih.gov/ medlineplus/
210. Navy US. Performance maintenance during continuous flight operations-a guide for flight surgeons. Fallon, NV: Naval Strike and Air Warfare Center; 2000.
211. Van den Heuvel CJ, Ferguson SA, Macchi MM, Dawson D. Melatonin as a hypnotic: con. Sleep Med Rev 2005; 9:71-80.
212. Van Dongen HPA. Comparison of mathematical model predictions to experimental data of fatigue and performance. Aviat Space Environ Med 2004; 75(3, Suppl)A122-4.
213. Van Dongen HP, Dinges DF. Sleep, circadian rhythms, and psychomotor vigilance. Clin Sports Med 2005; 24:237-49 (vii-viii.).
214. Van Dongen HPA, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: Dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003; 26:117-26.
215. Van Dongen HP, Mott CG, Huang JK, Mollicone DJ, McKenzie FD, Dinges DF. Optimization of biomathematical model predictions for cognitive performance impairment in individuals: accounting for unknown traits and uncertain states in homeostatic and circadian processes. Sleep 2007; 30:1129-43.
216. Van Dongen HP, Vitellaro KM, Dinges DF. Individual differences in adult human sleep and wakefulness: Leitmotif for a research agenda. Sleep 2005; 28:479-96.
217. Vgontzas AN, Pejovic S, Zoumakis E, Lin HM, Bixler EO, Basta M, et al. Daytime napping after a night of sleep loss decreases sleepiness, improves performance, and causes beneficial changes in Cortisol and interleukin-6 secretion. Am J Physiol Endocrinol Metab 2007; 292:E253-61.
218. Voderholzer U, Hornyak M, Thiel B, Huwig-Poppe C, Kiemen A, König A, et al. Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects. Neuropsychopharmacology 1998; 18:112-24.
219. Waterhouse J, Reilly T, Atkinson G. Jet-lag. Lancet 1997; 350:1611-6.
220. Waterhouse J, Reilly T, Atkinson G, Edwards B. Jet lag: trends and coping strategies. Lancet 2007; 369:1117-29.
221. Webb WB. The proximal effects of two and four hour naps within extended performance without sleep. Psychophysiology 1987; 24:426-9.
222. Wehr TA, Moul DE, Barbato G, Giesen HA, Seidel JA, Barker C, et al. Conservation of photoperiod-responsive mechanisms in humans. Am J Physiol 1993; 265:R846-57.
223. Weiss B, Laties VG. Enhancement of human performance by caffeine and the amphetamines. Pharmacol Rev 1962; 14:1-36.
224. Wells AS, Read NW, Uvnas-Moberg K, Alster P. Influences of fat and carbohydrate on postprandial sleepiness, mood, and hormones. Physiol Behav 1997; 61:679-86.
225. Wesensten N, Balkin T, Thorne D, Killgore R, Reichardt RM, Belenky G. Caffeine, dextroamphetamine modafinil during 85 hours of sleep deprivation. I. Performance and alertness effects. Aviat Space Environ Med 2004; 75(4, Suppl):B108.
226. Wesensten NJ, Belenky G, Kautz MA, Thorne D, Reichardt RM, Balkin T. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology (Berl) 2002; 159:238-47.
227. Wesnes K, Warburton DM. A comparison of temazepam and flurazepam in terms of sleep quality and residual changes in performance. Neuropsychobiology 1984; 11:255-9.
228. Wierwille WW, Ellsworth LA. Evaluation of driver drowsiness by trained raters. Accid Anal Prev 1994; 26:571
229. Wierwille WW, Wreggit SS, Kim CL, Ellsworth LA, Fairbanks RJ. Research on vehicle-based driver status/performance monitoring: development, validation, and refinement of algorithms for detection of driver drowsiness. Washington, DC: National Highway Traffic Safety Administration; 1994; Report No: DOT HS 808 247.
230. Wing YK. Herbal treatment of insomnia. Hong Kong Med J 2001; 7:392-402.
231. Wirz-Justice A, Armstrong SM. Melatonin, nature's soporific? J Sleep Res 1996; 5:137-41.
232. Wright N, McGown A. Vigilance on the civil flight deck: incidence of sleepiness and sleep during long-haul flights and associated changes in physiological parameters. Ergonomics 2001; 44:82-106.
233. Wright N, Powell D, McGown A, Broadbent E, Loft P. Avoiding involuntary sleep during civil air operations: Validation of a wrist-worn alertness device. Aviat Space Environ Med 2005; 76:847-56.
234. Yesavage JA, Leirer VO. Hangover effects on aircraft pilots 14 h after alcohol ingestion: a preliminary report. Am J Psychiatry 1986; 143:1546-50.
235. Youngstedt SD, O'Connor PJ, Dishman RK. Effects of acute exercise on sleep: a quantitative synthesis. Sleep 1997; 20:203-14.
236. Zammit GK, Kolevzon A, Fauci M, Shindledecker R, Ackerman S. Postprandial sleep in healthy men. Sleep 1995; 18:229-31.
237. Zhdanova IV. Melatonin as a hypnotic: pro. Sleep Med Rev 2005; 9:51-65.